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 48 
Summary 49 
Larvae of Galleria mellonella (Greater wax moth) have been shown to be 50 
susceptible to Campylobacter jejuni infection and our study characterises this 51 
infection model.  Following infection with C. jejuni human isolates, bacteria 52 
were visible in the hemocoel and gut of challenged larvae, and there was 53 
extensive damage to the gut.  Bacteria were found in the extracellular and cell 54 
associated fraction in the hemocoel, and we show that C. jejuni can survive in 55 
insect cells.  Finally, we have used the model to screen a further sixty-seven 56 
C. jejuni isolates belonging to different MLST types.  Isolates belonging to 57 
ST257 were the most virulent, whereas those belonging to ST21 were the 58 
least virulent in the Galleria model.  59 
 60 
Introduction 61 
Campylobacter jejuni is recognised as the leading cause of bacterial 62 
gastroenteritis across the developed world; the World Health Organisation 63 
estimates that 1% of the population of Western Europe is infected with 64 
campylobacters each year. It is thought that for each reported case, a further 65 
nine go unreported  (Humphrey et al., 2007), thus, based on the reported 66 
figures for 2009 from the Health Protection Agency, this would mean there 67 
were in excess of 500,000 cases in England and Wales alone.    Furthermore, 68 
beyond the initial diarrhoeal disease, C. jejuni may also cause post-infection 69 
complications including irritable bowel syndrome, meningitis and Guillain-70 
Barré Syndrome, plus its variant Miller-Fisher Syndrome (Janssen et al., 71 
2008; van Doorn et al., 2008). 72 
 73 
Despite having been first identified as a causative agent of diarrhoea in 1977 74 
(Skirrow, 1977), C. jejuni pathobiology remains poorly understood, with its 75 
core virulence determinants remaining elusive.  A major contributing factor in 76 
the lack of determination of these factors has been the absence of a suitable 77 
infection model for C. jejuni.  Previous models have included a ferret 78 
diarrhoeal model (Fox et al., 1987), a chick colonisation model (Wassenaar et 79 
al., 1993) and a colostrum deprived piglet model (Babakhani et al., 1993).  80 
However, in common with other mammalian and avian models, their 81 
widespread use has been limited by factors such as cost, ease of use, 82 
reproducibility and ethics (Newell, 2001).   83 
 84 
We recently reported that larvae of the lepidopteran insect Galleria mellonella 85 
(Greater wax moth) are susceptible to infection by C. jejuni and can be used 86 
to screen for virulence genes (Champion et al., 2010).  In this study we aimed 87 
to characterise G. mellonella as a C. jejuni infection model and to screen a 88 
panel of multi locus sequence typed (MLST) C. jejuni field isolates for 89 
virulence in G. mellonella.  Different MLST groups were chosen to cover types 90 
detected in the main food producing animals, the environment and clinical 91 
disease.     92 
 93 
Methods 94 
Strains and cultures 95 
All bacterial strains and mutants used in this study are shown in Table 1. C. 96 
jejuni strain 11168H is a hypermotile variant of the sequenced strain 97 
NCTC11168 that readily colonises chickens (Jones et al., 2004; Karlyshev et 98 
al., 2002). C. jejuni strains were cultured on either blood agar Skirrows 99 
actidione (BASA) plates or Columbia agar plates (CBA) supplemented with  100 
5% (v/v) horse blood in anaerobic jars in an atmosphere of 6% O2/10% CO2 101 
conditions (CampyPak, Oxoid) for 48 hours at 37ºC.  102 
 103 
For infections, bacteria were subcultured into 6ml of Mueller-Hinton (MH) 104 
broth (Oxoid) and grown under microaerobic conditions for 24 to 48 hours at 105 
37ºC, 150rpm.  The bacteria were then adjusted to OD590nm 1.0 in phosphate-106 
buffered saline (PBS, 0.1M, pH 7.2) for infections, equivalent to 1 x 108 cfu/ml.  107 
Infections at lower doses were adjusted accordingly.  108 
 109 
G. mellonella virulence assays 110 
G. mellonella larvae were purchased from Live Foods UK and maintained on 111 
wood chips at 15C. The infection of larvae was carried out as previously 112 
described (Champion et al., 2010) using a micro-injection technique whereby 113 
10µl of C. jejuni was injected into the hemocoel via the right fore leg, using a 114 
Hamilton syringe. Larvae were then incubated at 37oC and survival and 115 
macroscopic appearance recorded at 24 hours post-infection. PBS injected 116 
and uninfected controls were used. For each, experimental groups of ten G. 117 
mellonella larvae were infected.  118 
 119 
The association of C. jejuni with hemocytes 120 
A group of three G. mellonella larvae was infected as above with 106 cfu of C. 121 
jejuni 11168-H and incubated at 37ºC for 24 hours.  The larvae were chilled 122 
on ice for 20 minutes before aseptic removal of the bottom 2mm of the body.  123 
The hemocoel was drained from each larva into sterile microcentrifuge tubes 124 
and centrifuged at 200 x g for 5 minutes.  The supernatant, which was the 125 
hemolymph, was transferred to a separate sterile microcentrifuge tube.  The 126 
pelleted hemocytes were resuspended in 100μl of sterile distilled water, and 127 
pipetted up and down ten times to lyse the cells.  Serial dilutions of both 128 
hemolymph and hemocytes were plated out on CBA to enumerate bacteria. 129 
 130 
Histopathology 131 
C. jejuni-infected and uninfected larvae (5 per group) were fixed by immersion 132 
in 10% (v/v) neutral buffered formalin for 3-7 days. For light microscopy, 133 
larvae were blocked by a longitudinal section dividing the animal into two 134 
pieces and smears were air-dried and stained with Gram-Twort. The larvae 135 
(20%) were blocked into eleven transversal sections serially from the cranial 136 
to the caudal extremities of the larvae. Sections were embedded in paraffin 137 
wax and routinely stained with Haematoxylin and Eosin (H&E) for microscopic 138 
examination. 139 
 140 
Investigation of C. jejuni morphology following infection of G. mellonella 141 
A GFP-tagged C. jejuni strain, pREM5 11168H GFP (donated by Andrey 142 
Karlyshev) was cultured under microaerobic conditions on MH agar.  It was 143 
then subcultured into MH broth as before and incubated for 24 hours at 37ºC 144 
under microaerobic conditions.  An inoculum was prepared at OD590nm as 145 
previously described above.  Five G. mellonella larvae were infected with 10 146 
μl of the prepared inoculum, and a further five were inoculated with 10 μl of 147 
PBS.  The larvae were incubated at 37ºC for 3 hours before being chilled on 148 
ice for 5 minutes.  They were then swabbed with 70% ethanol prior to the 149 
aseptic removal of the bottom 2mm of the body as previously described.  One 150 
of each larval set was drained separately; the other 4 of each set had their 151 
hemocoel combined.  This combined hemocoel was centrifuged at 500 x g for 152 
5 minutes to pellet the hemocytes, and 10 μl of the supernatant (hemolymph) 153 
was dropped onto a slide.  A further 10 μl from the non-centrifuged hemocoel 154 
and 10 μl from the overnight C. jejuni culture were also dropped onto separate 155 
slides.  Slides were examined using a Zeiss LSM 510 META confocal 156 
microscope. 157 
 158 
Cell culture 159 
J774A.1, a murine monocyte macrophage-like cell line, was obtained from the 160 
American Type Culture Collection (ATCC), (Reference TIB-67), and was 161 
cultured in Dulbecco’s modified eagle medium (DMEM) supplemented with 162 
10% fetal bovine serum at 37ºC.  SF9, a lepidopteran cell line, was donated 163 
by Richard ffrench-Constant, and cultured in Grace’s Insect Medium (GIM) 164 
supplemented with 10% fetal bovine serum at 27ºC.  The cells were seeded at 165 
2 x 105 cells in 6-well tissue culture plates and then incubated at the 166 
appropriate temperature for 24 hours under 5% CO2 prior to infection with C. 167 
jejuni. 168 
 169 
Bacterial infection of cultured cells 170 
C. jejuni 11168-H was cultured on a CBA plate and harvested from an 171 
overnight culture by rolling a moistened swab over the plate; cells were re-172 
suspended in PBS.  OD590nm was measured and the inoculum was prepared 173 
at a Multiplicity of Infection (MOI) of 10 in L-15 medium before being added to 174 
both macrophages and insect cells (3 replicates).  The macrophages were 175 
incubated at 37ºC for 1 hour; the insect cells were incubated at 27ºC for 1 176 
hour.  Following incubation, the inoculum in each well was replaced with L-15 177 
medium containing 50 µg ml-1 gentamicin, and the plates then incubated at 178 
the appropriate temperature for a further 1 hour.  The medium was removed 179 
and the cells incubated in L-15 containing 10 µg ml-1 gentamicin for 180 
approximately 16 hours. 181 
 182 
The cells were then washed x3 with PBS, and 1ml cold sterile water was 183 
added to each well.  The cells were mechanically lysed to release intracellular 184 
bacteria, and colony forming units (cfu) were determined after plating out 185 
serial dilutions on CBA plates and incubating microaerobically at 37ºC. 186 
 187 
Results 188 
C. jejuni induces histopathological changes in G. mellonella  189 
In order to better understand the fate of C. jejuni inoculated into G. mellonella, 190 
larvae challenged with 106 cfu of some well-characterised human isolates 191 
were fixed in neutral buffered formalin at 24 hours post-infection and 192 
sectioned for histopathology.  Figure 1 shows H and E stained sections of 193 
uninfected and infected larvae.  Bacteria were observed in the hemocoel and 194 
sections of gut from infected larvae, but were absent in sections from 195 
uninfected controls.  There was evidence of damage to the midgut, with 196 
apoptotic cells and loss of integrity to the gut wall in the infected larvae.   This 197 
damage was not visible in the control sections.  Other tissues (fat body, 198 
muscle, nervous tissue) appeared undamaged in infected larvae and 199 
uninfected controls.  Pigmented nodules were also present in infected larvae, 200 
and bacteria were associated with these nodules.  These nodules were not 201 
visible in the uninfected control larvae. 202 
 203 
The observed bacteria were coccoid rather than having the characteristic 204 
spiral form associated with C. jejuni.  In order to investigate whether these 205 
coccoid bacteria were actually C. jejuni, G. mellonella larvae were infected 206 
with GFP-tagged C. jejuni; the hemocoel was collected and centrifuged at low 207 
speed to sediment hemocytes, which are often auto-fluorescent.  208 
Comparisons with C. jejuni from an overnight culture showed that these 209 
bacteria had the expected morphology, but bacteria in hemolymph were of a 210 
coccoid nature (Figure 2).  Similar observations of hemolymph from control 211 
larvae inoculated with PBS showed no fluorescence at all. 212 
 213 
To investigate the site of replication, hemocoel was collected and centrifuged 214 
at low speed to sediment hemocytes.  The number of bacteria found in the re-215 
suspended cell pellet (4.1 x 106 cfus; s.e.m 2.98 x 106) was broadly similar to 216 
the number found in the hemolymph (7.7 x 106 cfus; s.e.m 2.3 x 106). 217 
 218 
A macro scoring system was used to examine whether there was a correlation 219 
between the colour of the larvae and the presence of bacteria in the gut or 220 
body cavity (Table 2; Figure 3).  There was a significant association between 221 
macro colour and the presence of bacteria in the body cavity (p < 0.001, 222 
Kruskall-Wallis non-parametric test).  No associations were made between the 223 
location of the bacteria and temperature at which it had been grown, or 224 
location and the strain of C. jejuni used to inoculate the larvae. 225 
 226 
An insect cell line and mammalian macrophages are comparable in their 227 
response to challenge with C. jejuni  228 
Insect (SF9) and mammalian (J774A.1) cells were infected at an MOI of 10 229 
with C. jejuni 11168-H, and monitored at 4 hours and 24 hours post-infection.  230 
In J774A.1 macrophages, bacterial numbers declined 100-fold by 4 hours 231 
post-infection (Figure 4).  However, the bacterial numbers then remained 232 
approximately constant in the macrophages at 24 hours post-infection.  There 233 
was a broadly similar pattern of survival in the SF9 cell line.  Bacterial 234 
numbers decreased 1000-fold during the first 4 hours of the infection, but 235 
there was an approximate 10-fold increase in bacterial numbers between 4 236 
hours and 24 hours (Figure 4).  This increase was statistically analysed using 237 
a Student’s t-test and found to be significant (p < 0.05).   238 
 239 
Differences in virulence were observed in G. mellonella between C. 240 
jejuni Multi-Locus Sequence Typing (MLST) complexes 241 
To investigate whether there was an association between MLST type and 242 
virulence, larval survival was recorded following challenge with sixty-seven C. 243 
jejuni strains belonging to different MLST types (Figure 5).  It was observed 244 
that there was variation within MLST groups as well as between them.  There 245 
was a significant difference (p = 0.0002) between the ability of ST21 and 246 
ST257 strains to cause disease.  Overall, strains belonging to ST21 showed 247 
the least virulence in the model, whilst strains belonging to ST257 were the 248 
most virulent.     249 
 250 
Discussion 251 
We have previously demonstrated that G. mellonella larvae can be used to 252 
screen for virulence of Campylobacter genes (Champion et al., 2010).  In this 253 
study we have characterised the G. mellonella model and demonstrated that it 254 
can be used as an infection model to provide data about pathology and 255 
intracellular survival. 256 
 257 
Similarities between invertebrate and mammalian humoral and cellular innate 258 
immune responses are exploited when using insects as virulence models.  For 259 
example, G. mellonella possesses a cuticle that acts in the same physical 260 
barrier capacity as mammalian skin (Kemp & Massey, 2007).  Once the 261 
cuticle has been breached, G. mellonella induces a humoral response, 262 
producing soluble factors such as antimicrobial peptides (Mullett et al., 1993).  263 
In parallel with a humoral response, G. mellonella induces a cellular response 264 
to invading micro-organisms.  Insect hemocytes phagocytose bacteria in a 265 
manner similar to that of mammalian neutrophils and produce a respiratory 266 
burst (Bergin et al., 2005).  Thus, the response of G. mellonella to infection 267 
with C. jejuni is likely to have similarities to the response of humans. 268 
 269 
In the initial experiment, larvae were infected with human C. jejuni isolates 270 
11168-H, 11168-O, 81116, 81176 and 01/51.  These were selected as they 271 
are well-characterised in a number of other animal models; invasion and toxin 272 
data are also available for them.  It would not have been possible to fix G. 273 
mellonella for all the strains used later on, as this would have been time 274 
consuming and expensive with no guarantee of any further data. 275 
 276 
Histopathology of infected larvae demonstrated that bacteria are found in the 277 
hemocoel and in the gut and that extensive tissue damage occurs in the latter.  278 
This pathology may be caused by hemocytes in the gut tissue, which have 279 
ingested bacteria circulating in the hemocoel and then produced responses 280 
such as the release of free radicals and peroxide, causing the visible tissue 281 
damage.  The presence of pigmented nodules, which are aggregations of 282 
hemocytes around foreign bodies, indicates a vigorous immune response to 283 
infection (Lackie, 1980).  The observed colour change in infected larvae 284 
correlating with the presence of bacteria in the body cavity is a product of 285 
melanogenesis; this process is thought to protect endogenous tissues within 286 
the cavity from systemic damage resulting from pathogen killing (Nappi & 287 
Christensen, 2005).   288 
 289 
The bacteria observed in the larval sections were not identified, but were only 290 
present in Campylobacter infected larvae.  The bacterial cells were coccoid 291 
rather than spiral; however, C. jejuni that have become intracellular convert 292 
rapidly from the spiral form to the coccoid form (Kiehlbauch et al., 1985).  293 
There is some debate about how this change affects the bacteria (Moore, 294 
2001).  Adaptation to the coccoid form is generally seen as a response to 295 
stress, such as starvation or oxidative stress (Harvey & Leach, 1998).  Some 296 
studies, such as Moran & Upton (1986), have reported that the coccoid form is 297 
thus degenerative.  However, it has also been reported that coccoid C. jejuni 298 
become viable but non-culturable, with the potential to still act as an infectious 299 
agent (He & Chen, 2010).  To ascertain whether these coccoid cells were 300 
likely to be C. jejuni, a comparison was made between GFP-tagged C. jejuni 301 
grown in broth overnight versus the same bacteria inoculated into G. 302 
mellonella and incubated for 3 hours.   Under confocal microscopy, the 303 
fluorescing bacteria from broth were seen to be elongated, reflecting the 304 
normal spiral morphology of C. jejuni; the bacteria from the larval hemolymph 305 
were short and round like the coccoid bacteria seen in the larval sections.  306 
Hemolymph from PBS control larvae contained no fluorescing bacteria.  This 307 
observation suggests that the coccoid bacteria are indeed C. jejuni. 308 
 309 
Within the hemocoel, cell-associated and free bacteria were found.  C. jejuni 310 
is primarily an extracellular pathogen; however, intracellular survival 311 
has been hypothesised to play an important role in its pathogenesis 312 
(Kiehlbauch et al., 1985; Hickey et al., 2005; Young et al., 2007). 313 
Reproducible in vitro infection models that mimic pathogenesis in vivo have 314 
been used to study C. jejuni intracellular survival in epithelial cells (De Melo et 315 
al., 1989; Watson & Galan, 2008). However, reports of C. jejuni 316 
intramacrophage survival in vitro are conflicting. Some groups indicate that C. 317 
jejuni is killed by macrophages (Watson & Galan, 2008); others suggest that 318 
the bacteria survive within the macrophage (Day et al., 2000; Hickey et al., 319 
2005).  In this study, bacterial infection of different cell lines was undertaken to 320 
establish whether there was a difference in response between mammalian 321 
macrophages and an insect cell line.  It was uncertain as to whether C. jejuni 322 
would survive intracellularly in the SF9 insect cell line under tissue culture 323 
conditions.  However, although the levels of C. jejuni recovered from the 324 
insect cell line were approximately ten times lower than those recovered from 325 
murine macrophages at 4 hours post-infection, it is clear from the data 326 
presented here that the bacteria did invade the cells and survive within them.   327 
 328 
The bacterial numbers recovered from the macrophages remained consistent 329 
between 4 hours and 24 hours; there was survival within the macrophages.  330 
This is consistent with previous studies (Kiehlbauch et al., 1985; Hickey et al., 331 
2005).  However, there was a significant increase in recovered C. jejuni from 332 
the insect cell line at 24 hours compared to 4 hours.  Thus, it is possible that 333 
the bacteria not only survived within the cells, but also replicated.   334 
 335 
These observations are consistent with the hypothesis that C. jejuni enters 336 
insect hemocytes during in vivo model infections of G. mellonella.  This 337 
intracellular persistence may allow the bacteria to avoid, or at least reduce the 338 
impact of, host antimicrobial defences.  Nevertheless, the fact that at least 339 
some bacteria provoked the formation of melanised nodules is not surprising 340 
as it has previously been shown that nodule formation is associated with 341 
phagocytosis (Dean et al., 2004). 342 
 343 
C. jejuni strains can be classified by MLST complexes.  A number of studies 344 
have sought to establish whether there is a link between MLST type and the 345 
development of post-infectious complications (Dingle et al., 2001; Nielsen et 346 
al., 2009; Islam et al., 2009).  It was noted that the ST-22 complex is 347 
overrepresented in isolates from patients who have contracted Guillain-Barré 348 
Syndrome; no Guillain-Barré related isolates have been shown to carry ST-45, 349 
despite it being a common sequence type (Dingle et al., 2001; Nielsen et al., 350 
2009).    No sequence types have been found to be exclusive for clinical 351 
outcomes (Islam et al., 2009).  This supports the findings of Manning et al. 352 
(2003), who studied a large number of C. jejuni isolates and found that in 353 
terms of MLST types, the populations of veterinary and human isolates 354 
overlapped; it was suggested that most veterinary sources should be 355 
considered reservoirs of pathogenic campylobacters.  However, these studies 356 
did not assess whether bacteria from different MLST types exhibited different 357 
levels of virulence.  Recent studies have suggested that there may be 358 
associations between C. jejuni MLST type and virulence factors (Habib et al., 359 
2009; de Haan et al., 2010).  We observed that when bacteria selected as 360 
representatives of major MLST groups were put through the G. mellonella 361 
model, MLST type 257 strains were significantly more virulent than the MLST 362 
type 21 set.  MLST type 257 is mainly associated with poultry and clinical 363 
isolates.  MLST type 21 is common in all food producing animals; the strains 364 
used here are also all of clonal complex (CC) 21, which is one of the four most 365 
common CCs in human disease.  The reduced virulence of these isolates in 366 
the model may thus appear anomalous, but Habib et al. (2010) suggest that 367 
the abundant prevalence of C. jejuni of CC-21 may be a result of its increased 368 
tolerance of stresses encountered during the human food chain.  A less 369 
virulent but more stress tolerant strain would thus be encountered more 370 
frequently than a more virulent strain that did not tolerate such stresses to the 371 
same extent.  The convenience of the G. mellonella model allows for high 372 
throughput screening to assay for the differences in virulence.   Such a model 373 
could provide preliminary data when considering food security issues. 374 
 375 
This study has sought to further characterise G. mellonella as a model for C. 376 
jejuni infection, and suggests that, since the bacteria convert to a coccoid form 377 
once within the insect, it may be used to provide opportunities for further study 378 
of this morphological change.  The model may also prove useful in 379 
investigating the in vivo intracellular survival of C. jejuni within macrophages, 380 
an area of some dispute.  In particular, the model allows screening for natural 381 
variations in the virulence of C. jejuni field isolates, which would prove 382 
invaluable for tracking particularly virulent strains in the food chain.   383 
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Tables 498 
 499 
Strain  Origin   MLST group  500 
 501 
11168-H  Human   ST43/CC21 502 
11168-O  Human   ST43/CC21 503 
pREM5 11168H  Human   ST43/CC21 504 
81116  Human   ST267/CC283  505 
81176  Human   ST913/CC42 506 
01/51  Human   ST626/CC21 507 
01/43  Human   ST257/CC257 508 
93/372  Pet   ST21/CC21 509 
94/229  Poultry   ST45/CC45 510 
99/97  Human   ST45/CC45 511 
99/118  Cow   ST21/CC21 512 
99/188  Human   ST21/CC21 513 
99/189  Human   ST45/CC45 514 
99/194  Cow   ST45/CC45 515 
99/197  Human   ST45/CC45 516 
99/201  Cow   ST48/CC48 517 
99/202  Cow   ST45/CC45 518 
99/212  Human   ST45/CC45 519 
99/216  Human   ST45/CC45 520 
99/242  Poultry   ST45/CC45 521 
A1/CF/12  Poultry   ST257/CC257 522 
A6/T2/15  Poultry   ST257/CC257 523 
A8/35/15A Poultry   ST257/CC257 524 
C1/C/2  Poultry   ST257/CC257 525 
C120/2  Poultry   ST257/CC257 526 
C132/1  Poultry   ST19/CC21 527 
C3/T/25  Poultry   ST257/CC257 528 
C5/T2/8  Poultry   ST257/CC257 529 
C85-4-99-5 Cow   ST262/CC21 530 
C500-1-99-2 Cow   ST48/CC48 531 
C559-3-99-2 Cow   ST262/CC21 532 
D2/27/3  Poultry   ST48/CC48 533 
D2/T/8  Poultry   ST48/CC48 534 
D2/T/95  Poultry   ST48/CC48 535 
D5-20-9A  Poultry   ST262/CC21 536 
EX1182  Environmental  ST262/CC21 537 
EX1286  Poultry   ST262/CC21 538 
MB1  Poultry   ST48/CC48 539 
MB2  Poultry   ST48/CC48 540 
MB3  Poultry `  ST48/CC48 541 
MB4  Poultry   ST19/CC21 542 
MB5  Poultry   ST19/CC21 543 
MB6  Poultry   ST19/CC21 544 
MB7  Poultry   ST262/CC21 545 
MB8  Poultry   ST48/CC48 546 
MB9  Poultry   ST257/CC257 547 
MB10  Poultry   ST19/CC21 548 
MB12  Poultry   ST21/CC21 549 
MB13  Poultry   ST21/CC21 550 
MB14  Poultry   ST21/CC21 551 
MB15  Poultry   ST45/CC45 552 
MB16  Poultry   ST48/CC48 553 
MB17  Poultry   ST262/CC21 554 
MB18  Poultry   ST21/CC21 555 
Ps308  Pig   ST51/CC403 556 
Ps549.1   Pig   ST403/CC403 557 
Ps623  Pig   ST552/CC403 558 
Ps762  Pig   ST270/CC403 559 
Ps830  Pig   ST403/CC403 560 
Ps838  Pig   ST403/CC403 561 
Ps843  Pig   ST403/CC403 562 
Ps849  Pig   ST403/CC403 563 
Ps852  Pig   ST270/CC403 564 
Ps857  Pig   ST270/CC403 565 
S39-2-99-3 Sheep   ST21/CC21 566 
S87-4-99-3 Sheep   ST262/CC21 567 
S120-4-99-4 Sheep   ST45/CC45 568 
S216-5-99-1 Sheep   ST257/CC257 569 
S372-5-99-4 Sheep   ST21/CC21 570 
S379-8-99-1 Sheep   ST262/CC21 571 
S435-3-99 Sheep   ST262/CC21 572 
S499-1-99-5 Sheep   ST19/CC21 573 
S585-3-99 Sheep   ST19/CC21 574 
 575 
 576 
 577 
 578 
 579 
Table 1: A table describing the bacterial strains used in this study 
C. jejuni strain Incubation 
temperature 
Animal 
number 
Macro 
colour 
Bacteria in 
gut 
Bacteria in 
cavity 
Mean 
Galleria 
survival 
01/51 37ºC 1 0 3 0 80% 
2 2 3 3 
3 3 3 3 
4 3 3 3 
5 3 2 2 
42ºC 1 2 3 3 82% 
2 2 3 2 
3 2 2 1 
4 2 3 3 
5 2 3 3 
11168-O 37ºC 1 1 2 3 27% 
2 1 3 3 
3 2 3 3 
4 2 3 3 
5 3 3 3 
42ºC 1 1 3 2 80% 
2 2 2 2 
3 2 1 2 
4 2 3 3 
5 2 3 3 
11168-H 37ºC 1 1 2 3 0% 
2 1 2 1 
3 2 3 3 
4 2 1 0 
5 3 3 2 
42ºC 1 0 2 0 ND 
2 1 3 1 
3 1 2 1 
4 2 3 1 
5 3 3 3 
81116 37ºC 1 1 2 0 90% 
2 1 3 0 
3 3 3 3 
4 3 3 3 
5 3 3 3 
42ºC 1 1 2 2 65% 
2 1 2 0 
3 2 3 2 
4 2 2 0 
5 3 1 3 
81176 37ºC 1 1 2 0 90% 
2 1 2 0 
3 2 2 0 
4 2 2 1 
5 3 2 3 
42ºC 1 2 2 2 75% 
2 2 3 3 
3 2 3 3 
4 3 2 3 
5 3 3 3 
PBS  1 0 1 0 100% 
2 0 2 0 
3 0 2 0 
4 0 2 0 
5 1 1 0 
Uninfected  1 0 1 0 100% 
2 0 1 0 
3 0 1 0 
4 0 2 0 
5* 1 3 3 
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Table 2:  Macro scores for different C. jejuni strains in terms of colour, presence of 
bacteria in the larval gut and presence of bacteria in the larval body cavity.  G. 
mellonella were incubated at different temperatures. * autolysis.  A score of 3 for 
macro colour refers to fatality.  ND = no data. 
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Figure 1:  H&E stained sections of Galleria mellonella.  (A)  Non-infected larva (Bar: 
100µm).  (B) Control [0.1M PBS inoculation] larva.  (Bar: 100µm) (C) Larva infected 
with C. jejuni 81116 and incubated at 37ºC (Bar: 250µm).  (D) Larva infected with C. 
jejuni 81116 and incubated at 42ºC (Bar: 100µm).  Structures annotated as follows:  a 
– adipose bodies, b – bacterial colonies, c – cuticle, h – hemolymph, m – muscle, p – 
pigmented structures.  
  
Figure 3:  Macroscopic evaluation of wax moth larvae following infection with 
C. jejuni: white, score 0; orange, score 1; black, score 3 
Figure 2:  confocal microscope images of GFP-tagged C. jejuni pREM5 11168H.  
Left:  C. jejuni from an overnight broth culture.  Right:  C. jejuni in the 
hemolymph of infected G. mellonella after 3 hours’ incubation. 
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Figure 4:  A chart to show the average numbers of C. jejuni 11168-H recovered 
from J774.1A murine macrophages and SF9 insect cell line at 4 hrs and 24 hrs 
post-infection (n = 3).  0 hrs represents the initial inoculum. 
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Figure 5:  A graph of data from MLST infections of G. mellonella.  Each 
spot represents the average percentage larval survival (n = 10).  Horizontal 
lines represent the mean for each MLST type. 
